In patients with isolated anti-Centromere antibody positivity and Raynaud's phenomenon without other features of systemic sclerosis, what is your approach to screening for pulmonary complications?

In patients with isolated anti-centromere antibody (ACA) positivity and Raynaud's phenomenon, even without overt systemic sclerosis, the primary concern is pulmonary arterial hypertension (PAH), which can develop at any point, including decades after initial presentation. Notably, ACA-positive patie...

If you examine the data from the VEDOSS registry (very early diagnosis of systemic sclerosis), patients with Raynaud's and a scleroderma-specific autoantibody have a very high likelihood of developing classification criteria for systemic sclerosis, so they should be thought of as either a mild form ...